S&P 500

5.431,60

-0,04%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Interpace Biosciences Inc (QX) (IDXG)
Interpace Biosciences Inc (QX) (IDXG) Notícias

IDXG

Interpace Biosciences (QX) (IDXG)

Interpace Biosciences Inc (QX)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:IDXG

1

Data	Hora	Fonte	Título	Código	Companhia
09/05/2024	17:29	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:IDXG	Interpace Biosciences Inc (QX)
12/02/2024	19:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:IDXG	Interpace Biosciences Inc (QX)
06/02/2024	08:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:IDXG	Interpace Biosciences Inc (QX)
08/11/2023	18:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:IDXG	Interpace Biosciences Inc (QX)
22/09/2023	17:53	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	USOTC:IDXG	Interpace Biosciences Inc (QX)
22/09/2023	17:20	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:IDXG	Interpace Biosciences Inc (QX)
12/05/2023	17:35	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:IDXG	Interpace Biosciences Inc (QX)
12/05/2023	17:24	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:IDXG	Interpace Biosciences Inc (QX)
03/05/2023	16:17	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:IDXG	Interpace Biosciences Inc (QX)
28/04/2023	17:20	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:IDXG	Interpace Biosciences Inc (QX)
27/03/2023	17:40	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:IDXG	Interpace Biosciences Inc (QX)
20/09/2022	17:47	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:IDXG	Interpace Biosciences Inc (QX)
20/09/2022	17:37	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:IDXG	Interpace Biosciences Inc (QX)
09/09/2022	17:29	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:IDXG	Interpace Biosciences Inc (QX)
02/02/2022	18:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:IDXG	Interpace Biosciences Inc (QX)
01/02/2022	12:16	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:IDXG	Interpace Biosciences Inc (QX)
13/01/2022	08:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:IDXG	Interpace Biosciences Inc (QX)
13/01/2022	08:05	Edgar (US Regulatory)	Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)	USOTC:IDXG	Interpace Biosciences Inc (QX)
26/04/2021	09:53	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	USOTC:IDXG	Interpace Biosciences Inc (QX)
01/03/2021	18:07	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:IDXG	Interpace Biosciences Inc (QX)